Divis Gregory J
SEC insider (Form 3/4/5 filer). CIK 0001410677. Chief Executive Officer at AVADEL PHARMACEUTICALS PLC (AVDL). 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 12, 2026. Located in DUBLIN 2, L2.
Companies Divis Gregory J has filed insider reports for
- AVADEL PHARMACEUTICALS PLC (AVDL): Director, Officer, Chief Executive Officer
Divis Gregory J
CIK: 0001410677
Transaction Breakdown
Open Market Buys (P)2 (40.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (20.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (40.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AVDL
AVADEL PHARMACEUTICALS PLC
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Feb 12, 2026AVDL
AVADEL PHARMACEUTICALS PLC
DispositionDirect211.1K shares at avg. $21.00$4.4M - Feb 12, 2026AVDL
AVADEL PHARMACEUTICALS PLC
DispositionIndirect10K shares at avg. $21.00$210K - Mar 5, 2025AVDL
AVADEL PHARMACEUTICALS PLC
AwardDirect52K shares- - Dec 9, 2024AVDL
AVADEL PHARMACEUTICALS PLC
PurchaseIndirect402 shares at avg. $9.82$4K - Dec 6, 2024AVDL
AVADEL PHARMACEUTICALS PLC
PurchaseIndirect9.6K shares at avg. $9.98$96K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | Disposition | 211,105 | $21.00 | $4,433,205 | Direct |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | Disposition | 10,000 | $21.00 | $210,000 | Indirect |
| Mar 5, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | Award | 52,000 | - | - | Direct |
| Dec 9, 2024 | AVDL AVADEL PHARMACEUTICALS PLC | Purchase | 402 | $9.82 | $3,948 | Indirect |
| Dec 6, 2024 | AVDL AVADEL PHARMACEUTICALS PLC | Purchase | 9,598 | $9.98 | $95,759 | Indirect |
1-5 of 5 transactions